TAK News and Press, Takeda Pharmaceutical Company Limited American Depositary Shares From 10/27/25

2025-10-27 14:56:47 ET Read the full article on Seeking Alpha For further details see: Harmony Biosciences: Performing Commercially But Competition Afoot

Dedicated Devices for HYQVIA [Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase] Reduce the Number of Steps and Ancillary Supplies Compared to a Pooling Bag When Preparing the HYQVIA Infusion 1,2 HyHub and HyHub Duo Represent Takeda’s First Devices ...

2025-10-26 09:05:22 ET More on The Health Care Select Sector SPDR® Fund ETF XLV: Lower Interest Rates And A Positive Growth Outlook Will Pave The Way XLV: Market Overreaction Could Drive Double Digit Shareholder Yield XLV Vs. IHE: Will Pharmaceuticals Outperform...

2025-10-22 13:33:50 ET Takeda Pharmaceutical Company Limited (TAK) Discusses Global Strategic Collaboration for Next-Generation Oncology Assets and ADC Molecules October 22, 2025 9:00 AM EDT... Read the full article on Seeking Alpha For further details see: Takeda Pharmaceut...

2025-10-22 01:55:39 ET More on Innovent Biologics, Takeda Pharmaceutical Takeda: Excellent Pipeline Kaizen - 6 Drugs, $20 Billion Annually Takeda Pharmaceutical Company Limited (TAK) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript Taked...

Takeda to Receive Rights to Two Next-Generation Late-Stage Investigational Medicines, Worldwide Outside of Greater China, and an Exclusive Option to License Global Rights to an Early-Stage Program Takeda to Lead IBI363 Global Co-Development and U.S. Co-Commercialization and Will Have ...

2025-10-13 10:09:05 ET Thesis It's been a busy week for Protagonist Therapeutics, Inc. (PGTX) in terms of news. They're a name that wouldn't have been on everyone's map before the interest shown by Johnson & Johnson ( JNJ ) ("J&J"); however, after last week, their stock ...

2025-10-10 11:36:01 ET More on Johnson & Johnson, Protagonist Johnson & Johnson: A Safe Haven That's Quietly Becoming A Bit Overpriced Johnson & Johnson (JNJ) Presents at Bernstein 2nd Annual Global Healthcare Conference Transcript Protagonist Therapeutic...

2025-10-06 13:29:00 ET On September 17 , the Fed began cutting interest rates again, which historically preceded Big Pharma's increased activity in the M&A space.... Read the full article on Seeking Alpha For further details see: My Top 5 Biotech Stocks Big Pharm...

2025-09-26 04:59:57 ET More on drugmakers AstraZeneca: Oncology Breakthroughs And Farxiga Surge Excite Investors Takeda: Excellent Pipeline Kaizen - 6 Drugs, $20 Billion Annually GSK plc (GSK) plc Presents at Bank of America Global Healthcare Conference 2025 Transcri...